Miscellaneous Research Thread

forestglip

Moderator
Staff member
I think it'd be good to have a general thread for topics related to research that don't need a whole thread and for where there is no existing relevant thread to post to.

So I'm making this thread as a catch-all for research related topics (from any conditions) that don't fit elsewhere.
 
Paywalled and no abstract, but maybe there's something interesting in this:

The association between glucocorticoids and long COVID (2025, Inflammopharmacology)
A letter to the editor, commenting on a recent study which linked glucocorticoid therapy in COVID-19 patients to an increased risk of long COVID. The authors suggest caution in interpreting its results, mentioning potential confounding factors (disease severity, inflammation levels) & study limitations (lack of information about dosage, timing, treatment duration). They recommend that future research includes subgroup analyses involving factors such as inflammation severity & cortisol levels.
 
A letter to the editor, commenting on a recent study which linked glucocorticoid therapy in COVID-19 patients to an increased risk of long COVID. The authors suggest caution in interpreting its results, mentioning potential confounding factors (disease severity, inflammation levels) & study limitations (lack of information about dosage, timing, treatment duration). They recommend that future research includes subgroup analyses involving factors such as inflammation severity & cortisol levels.
Thanks!
 

Omega-3 fatty acids were once believed to protect against and even heal many diseases. Psychiatrist Gregor Berger dedicated over 30 years to researching their effects on mental illnesses such as depression and psychosis. His conclusion: their benefits are largely overestimated.

The hype around omega-3 began with observations of the Inuit, who had healthier hearts and lower rates of schizophrenia despite a fatty diet. This was linked to their high levels of EPA and DHA, essential fatty acids found in fish and algae. Early lab and small clinical studies suggested anti-inflammatory and neuroprotective effects, which fueled global research and supplement sales.

However, large clinical trials brought disappointment. Omega-3 capsules showed no significant effect on psychosis progression or depression in children and adolescents. Similar results were found for heart disease, cancer, dementia, and autoimmune conditions: only minor benefits for a few individuals, with no clear population-wide effect. In some heart patients, omega-3 supplements even increased the risk of arrhythmia.

The only proven effect is a reduction in certain blood lipids. Eating fish cannot simply be replaced by taking capsules. Berger now focuses on specific subgroups that might still benefit—people with a significant omega-3 deficiency or underlying inflammation. He hopes future studies will clarify whether targeted use could help these patients.
 
Eating fish cannot simply be replaced by taking capsules.
As I am unable to get past the paywall, is the assertion that eating fish does have the benefits previously ascribed to omega-3s/DHA/EPA alone? If not, to what is this statement referring?

I note that the quoted excerpt does still imply potential help for those with "inflammation."
 
Last edited:
As I am unable to get past the paywall, is the assertion that eating fish does have the benefits previously ascribed to omega-3s/DHA/EPA alone? If not, to what is this statement referring?

I note that the quoted excerpt does still imply potential help for those with "inflammation."
Good question, unfortunately the article isn’t that clear about it.
Earlier in the article they briefly mention results that showed benefits of a fish diet and tests in cells against inflammation.

Later the article states:
"All the studies and tests have taught me one thing," says Berger. "Nutrition and dietary supplements are absolutely not the same. Food works very differently from powders and capsules." A plate full of salmon and mackerel cannot simply be replaced by omega-3 capsules. Moreover, no one can say for sure whether it is only the omega-3 fatty acids that keep the Inuit’s hearts healthy.
 

AI Summary:
mRNA COVID Vaccines May Boost Cancer Immunotherapy Outcomes

A Surprising Link Between Vaccination and Cancer Survival


New research suggests that mRNA COVID-19 vaccines might improve survival rates for cancer patients undergoing immunotherapy. An analysis of nearly 1000 patient records found that individuals who received an mRNA vaccine within 100 days of starting immune checkpoint inhibitors lived significantly longer. For advanced lung cancer patients, survival nearly doubled — from 20 months to around 37 months.

Checkpoint Inhibitors and Immune Activation

Immune checkpoint inhibitors are a class of cancer drugs that work by preventing “off switches” on immune cells from being activated by tumours. One such switch is PD-1, which can be flipped off by the tumour’s production of PD-L1. Blocking this interaction allows immune T-cells to keep attacking cancer cells. However, these drugs are only effective if the immune system is already engaged against the tumour.

How mRNA Vaccines Fit In

Cancer vaccines are usually custom-made to provoke the immune system against specific tumour proteins. These are expensive and time-consuming to produce. Unexpectedly, researchers observed that non-specific mRNA vaccines — even those not designed to target cancer — activated the immune system in a powerful way. In mice studies, these vaccines triggered an innate immune alarm, drawing T-cells from tumours to lymph nodes, where they could coordinate stronger attacks.

Real-World Data and Early Results

At the University of Texas MD Anderson Cancer Center, researchers found that vaccinated lung cancer patients receiving checkpoint inhibitors lived nearly twice as long as those who weren’t vaccinated within the same time frame. A similar trend appeared in melanoma patients, with survival times ranging from 30 to 40 months for vaccinated individuals, compared to 27 months in others.

Looking Ahead

While the data is promising, researchers like Elias Sayour caution against making clinical decisions based on these findings alone. A formal clinical trial is scheduled to begin before the end of 2025 to test the connection further. Past case reports have shown tumours shrinking after mRNA COVID-19 vaccination, even without immunotherapy — hinting at broader potential, though more studies are needed.

Concerns About Funding Cuts

Despite these promising findings, the U.S. government has recently reduced funding for mRNA vaccine development. Experts warn that this could hinder progress on what may be a transformative tool in both infectious disease and cancer treatment.
 

Study: MRI contrast agent causes harmful metal buildup in some patients​


“I wouldn’t take vitamin C if I needed to have an MRI with contrast because of the reactivity of the metal,” Wagner said.

Study in question:
 
This appeared in my search alerts today - have not been able to read through but judging by the abstract may be of potential interest -

Attentional failures after sleep deprivation are locked to joint neurovascular, pupil and cerebrospinal fluid flow dynamics (Nature Neuroscience, October 2025)

Abstract:
Sleep deprivation rapidly disrupts cognitive function and in the long term contributes to neurological disease. Why sleep deprivation has such profound effects on cognition is not well understood. Here we use simultaneous fast fMRI–EEG to test how sleep deprivation modulates cognitive, neural and fluid dynamics in the human brain. We demonstrate that attentional failures during wakefulness after sleep deprivation are tightly orchestrated in a series of brain–body changes, including neuronal shifts, pupil constriction and cerebrospinal fluid (CSF) flow pulsations, pointing to a coupled system of fluid dynamics and neuromodulatory state.
CSF flow and hemodynamics are coupled to attentional function within the awake state, with CSF pulsations following attentional impairment. The timing of these dynamics is consistent with a vascular mechanism regulated by neuromodulatory state. The attentional costs of sleep deprivation may thus reflect an irrepressible need for rest periods driven by a central neuromodulatory system that regulates both neuronal and fluid physiology.
 
This popped up in a search. Looked potentially interesting but quickly became clear it’s one of those papers that conflates ME/CFS, CFS and fatigue

The Association Between the Occurence of Sensory Integration Disorders, Depression, and Chronic Fatigue Syndrome in Patients with Relapsing-Remitting Multiple Sclerosis, 2025, Machowska-Sempruch et al

Machowska-Sempruch, Karolina; Masztalewicz, Marta; Meller, Agnieszka; Nowacki, Przemysław; Pawlukowska, Wioletta

Abstract
Background: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system associated with both motor and non-motor symptoms. Depression and chronic fatigue syndrome (CFS) are frequent in relapsing–remitting MS (RRMS), but the role of sensory integration disorders (SID) remains unclear. Methods: This cross-sectional study included 205 RRMS patients (147 females, 58 males; aged 19–69 years) treated at the Pomeranian Medical University, Szczecin (2022–2023). SID were evaluated using the Daniel Travis Questionnaire, depression using the Beck Depression Inventory (BDI), fatigue using the Fatigue Scale for Motor and Cognitive Functions (FSMC), and disability using the Expanded Disability Status Scale (EDSS). MRI T2 lesion counts and relapse rates were analyzed using non-parametric tests (p < 0.05). Results: SID were significantly associated with depression severity. Patients with moderate to severe depression showed greater impairment in sensory discrimination, motor abilities, and emotional functioning (p < 0.05). Higher disability (EDSS > 3) and longer disease duration correlated with worse SID scores. Relapse frequency was linked to poorer sensory-seeking and emotional domains, while no association was found between SID and CFS or MRI lesion load. Conclusions: SID are prevalent in RRMS and correlate with depression, disease duration, and disability, suggesting potential therapeutic value in sensory-based rehabilitation.

Web | MDPI AG
https://doi.org/10.20944/preprints202511.0278.v1
 
The occurrence of chronic fatigue syndrome was based on a questionnaire survey including a validated questionnaire for chronic fatigue syndrome - Fatigue Syndrome Scale for Motor and Cognitive Functions (FSMC)

So they seem to use this FSMC Fatigue Scale to determine if people had fatigue and then called that CFS or sometimes ME/CFS

Few studies have examined the characteristics of noise and lights hypersensitivities in adults with CFS or MS. For instance, studies have found prevalence rates of lights hypersensitivity among people with CFS to vary between 48–90. No study has determined prevalence rates for noise hypersensitivity among people with ME/CFS or MS.
 
Another longer article on Omega 3 supplements:

AI Summary:
Is Omega-3 Really a Super Booster?

The Global Omega-3 Boom​

Demand for Omega-3 is immense: it is believed to prevent dementia and heart disease, improve mood and intelligence, and even slow aging. After vitamins and minerals, Omega-3 is the most popular supplement in the United States, driving a billion-dollar global industry with annual growth near eight percent.

Origins of the Hype​

The modern Omega-3 boom began in the 1970s, when scientists discovered that fish contain polyunsaturated fatty acids with significant health benefits. The two key types, EPA and DHA, cannot be produced by the human body and must be obtained from fish or algae. Once consumed, these fatty acids are absorbed into the bloodstream and incorporated into cell membranes throughout the body—especially in the brain, retina, and sperm cells. They help keep cell membranes flexible and may improve the performance of nerve and blood cells.

Molecular Effects and Promises​

On a molecular level, Omega-3 influences several biological processes. It reduces blood clotting, lowers harmful fats, and suppresses inflammation—similar to aspirin. It also affects neurotransmitter metabolism, influencing mood, learning, and motivation. Studies suggest that people with high Omega-3 levels have lower risks of heart attacks, Alzheimer’s, and autoimmune diseases. Observational research consistently links fish-rich diets with longer, healthier lives.

The Question of Evidence​

Despite the promising biology, doubts remain. Are these effects real or exaggerated? To explore this, the author interviews Ulrich Bauhofer, a 70-year-old doctor and influencer advocating supplements from Vitamin D to Omega-3. Bauhofer claims modern food lacks nutrients due to industrial farming and believes supplements restore balance. In his Munich practice, he recommends algae-based Omega-3 oils to patients with low fish consumption, noting contamination concerns with some fish species.

Contradicting Findings​

Nutrition researcher Lee Hooper from the University of East Anglia represents the skeptical side. For Cochrane, she analyzed hundreds of randomized controlled trials, the strictest type of medical research. These studies compared groups taking Omega-3 supplements or eating more fish against those taking placebos. Her conclusion: very little clear evidence of benefit. Small, inconsistent effects were seen across studies. Neither EPA nor DHA significantly reduced heart attacks, dementia, or overall mortality.

Explaining the Discrepancies​

Hooper suggests that lifestyle differences explain much of Omega-3’s reputation. People who eat more fish often live healthier lives overall—they are wealthier, exercise more, and have better social conditions. This creates false correlations between Omega-3 intake and good health. She emphasizes that nutrition science often confuses association with causation. Laboratory effects or correlations in observational studies cannot justify universal supplement recommendations without strong experimental proof.

The Complexity of Nutrition​

Hooper also notes that food works as a whole system: nutrients interact in complex ways. Fatty fish contains not only Omega-3 but also selenium, protein, vitamin D, and iodine, all potentially beneficial. Capsules cannot replicate this natural combination. Furthermore, eating fish may improve health simply because it replaces unhealthy foods such as processed meat. This substitution effect may explain many benefits seen in fish eaters. For that reason, Germany’s nutrition society recommends eating fish once or twice per week but does not advise routine Omega-3 supplementation, except for pregnant and breastfeeding women who avoid fish.

Modern Diets and the Omega Balance​

Still, some scientists argue the modern diet has shifted the natural balance between Omega-3 and Omega-6 fatty acids. Industrial food production uses massive amounts of Omega-6-rich oils like sunflower, soy, and palm oil. These compete with Omega-3 in the body and reduce its effectiveness. Humans now consume thousands of times more soy oil than in the past, leading some to believe that supplements might help restore equilibrium.

Reassessing Deficiency and Individual Needs​

Nutrition professor Martin Smollich disagrees with the idea of a widespread Omega-3 deficiency. He argues there is no scientifically defined threshold for deficiency, and if billions of people with low fish intake truly lacked Omega-3, the health effects would be dramatic and obvious. Nevertheless, other researchers, such as food chemist Nils Helge Schebb, believe population averages may conceal individual differences. Many clinical trials might have included participants with already sufficient Omega-3 levels, hiding potential benefits for those truly deficient.

Evidence for Specific Groups​

The large U.S. VITAL study, involving 26,000 people, showed only minor overall benefits from Omega-3 supplements. However, participants who rarely ate fish experienced substantial improvements—a 40 percent reduction in heart attacks and 20 percent fewer severe cardiovascular events. This suggests that supplementation could help specific subgroups rather than everyone.

A Balanced Conclusion​

The author’s personal conclusion is cautious optimism. Omega-3 supplements appear safe and possibly beneficial, especially for those who eat little fish, but their effects are modest—far weaker than those of medicines. No capsule can replace an overall healthy diet.
 
Last edited:
Back
Top Bottom